Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nathalie, Brion"'
Publikováno v:
Vrije Universiteit Brussel
The invasion of alien macrophytes in aquatic ecosystems has caused serious ecological and economic impacts. Their introduction often leads to competition with natives and already established invasive species. Competition among invasive species is ass
Autor:
Nathalie Brion, Bernard Paule
Publikováno v:
Journal of Cancer Therapy. :10-20
Patients who have undergone a radical prostatectomy may have to face high risks of recurrence. The risk of recurrence is elevated due to probable occult metastatic disease at the time of diagnosis. A rationale for using multimodal approach in order t
Autor:
Nathalie Brion, Britta Gribsholt, Eric Struyf, Henricus T. S. Boschker, L. De Brabandere, S. Van Damme, F.A. Dehairs, Patrick Meire, A. Tramper, Jack J. Middelburg
Publikováno v:
Biogeosciences. 4:11-26
An intact tidal freshwater marsh system (3477 m2) was labelled by adding 15N-ammonium as a tracer to the flood water inundating the ecosystem. The appearance and retention of 15N-label in different marsh components (leaves, roots, sediment, leaf litt
Autor:
Nathalie Brion, Jean-Paul Demarez, Chantal Belorgey, P. Amiel, F. Berger, C. Bernaud, N. Best, I. Brindel, F. Chapuis, M. Couderc, S. Courcier Duplantier, F. De Crémiers, A. Deneulin, V. Diebolt, T. Dupin Spriet, C. Funck Brentano, J. Genève, C. Guérin, A. Guillardeau Jaillon, S. Hansel, S. Hilaly, P. Lechat, F. Lemaire, F. Loeb, G. Loeb, A. Mijonnet, J. Moret Bailly, C. Nourissier, C. Oréfice, J.-M. Laurent Vo, Y. Plétan, T. Roche, P. Sassano, C. Sibenaler, B. White Gay
Publikováno v:
Therapies. 60:329-337
The transposition into French law of Directive 2001/20/CE, which relates to good clinical practice in the conduction of trials on drugs for human use, has required the modification of certain provisions that concern the protection of persons particip
Autor:
Nathalie Brion, Jean-Paul Demarez, Chantal Belorgey, P. Amiel, F. Berger, C. Bernaud, N. Best, I. Brindel, F. Chapuis, M. Couderc, S. Courcier Duplantier, F. De Crémiers, A. Deneulin, V. Diebolt, T. Dupin Spriet, C. Funck Brentano, J. Genève, C. Guérin, A. Guillardeau Jaillon, S. Hansel, S. Hilaly, P. Lechat, F. Lemaire, F. Loeb, G. Loeb, A. Mijonnet, J. Moret Bailly, C. Nourissier, C. Oréfice, J.-M. Laurent Vo, Y. Plétan, T. Roche, P. Sassano, C. Sibenaler, B. White Gay
Publikováno v:
Therapies. 60:319-328
Resume La transposition de la directive 2001/20/CE relative aux bonnes pratiques cliniques dans la conduite des essais de medicaments a usage humain a necessite la modification de certaines dispositions du droit francais en matiere de protection des
Autor:
Yves Lambert, Nathalie Brion, Nathalie Degrèze, Joël Cléro, Kolia Milojevic, Isabelle Chassagnol
Publikováno v:
Therapies. 59:611-614
Resume Methodes Dans le but d’evaluer les connaissances et les pratiques concernant la notification des effets indesirables (EI) survenant en medecine d’urgence, une enquete a ete realisee entre juin et septembre 2002 dans une region francaise. C
Publikováno v:
Journal of sea research
Suspended particulate organic matter was sampled monthly between June 1999 and April 2000 in the Scheldt river and estuary to investigate the seasonal and spatial patterns of δ 13 C and δ 15 N signatures. δ 15 N of suspended matter showed large se
Publikováno v:
Water Research. 33:3521-3531
In order to study the impact on the river Seine of the waste water effluents from the city of Paris and its suburbs, a detailed characterisation was made of both raw and treated effluents from the three main treatment plants in this area which differ
Autor:
Bernard, Paule, Nathalie, Brion
Publikováno v:
Anticancer research. 31(10)
Therapy of patients with metastatic renal cell carcinoma (mRCC) requires sequential use of several agents with different mechanisms and minimal cross-resistance between the different agents. Tyrosine kinase inhibitors (TKIs) and mammalian target of r
Autor:
Bernard, Paule, Nathalie, Brion
Publikováno v:
Anticancer research. 31(1)
Chromophobe renal cell carcinoma (chRCC) is a common subtype of renal cell carcinoma (RCC), occurring in 6-11% of renal carcinoma patients. Limited clinical trial data have shown minimal activity with cytokines and chemotherapy, although small-molecu